United States
# |
Name |
Operating Income |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 42.57 B
|
Dec. 31, 2024 | USD 405.10 | 2.38% |
|
United States |
|
2 |
USD 32.29 B
|
Dec. 31, 2024 | USD 548.18 | 1.05% |
|
United States |
|
3 |
USD 28.74 B
|
Oct. 31, 2024 | USD 99.54 | 1.41% |
|
United States |
|
4 |
USD 22.12 B
|
Sept. 29, 2024 | USD 151.87 | -0.18% |
|
United States |
|
5 |
USD 14.87 B
|
Sept. 30, 2024 | USD 99.79 | 0.98% |
|
United States |
|
6 |
USD 14.44 B
|
Sept. 30, 2024 | USD 810.43 | -0.08% |
|
United States |
|
7 |
USD 13.82 B
|
Sept. 30, 2024 | USD 190.14 | 3.39% |
|
United States |
|
8 |
USD 10.50 B
|
Sept. 30, 2024 | USD 334.30 | 1.33% |
|
United States |
|
9 |
USD 10.31 B
|
Sept. 30, 2024 | USD 59.95 | 1.70% |
|
United States |
|
10 |
USD 10.13 B
|
Sept. 29, 2024 | USD 26.20 | -1.21% |
|
United States |
|
11 |
USD 9.52 B
|
Sept. 30, 2024 | USD 55.95 | -0.94% |
|
United States |
|
12 |
USD 8.38 B
|
Sept. 30, 2024 | USD 98.38 | 1.21% |
|
United States |
|
13 |
USD 7.33 B
|
Dec. 31, 2024 | USD 593.75 | -0.67% |
|
United States |
|
14 |
USD 6.90 B
|
Sept. 30, 2024 | USD 128.45 | 0.41% |
|
United States |
|
15 |
USD 6.11 B
|
Sept. 30, 2024 | USD 288.87 | 1.21% |
|
United States |
|
16 |
USD 4.86 B
|
Dec. 31, 2024 | USD 214.26 | -3.81% |
|
United States |
|
17 |
USD 4.51 B
|
Nov. 9, 2024 | USD 63.33 | 2.74% |
|
United States |
|
18 |
USD 4.00 B
|
Sept. 30, 2024 | USD 666.85 | -0.91% |
|
United States |
|
19 |
USD 3.80 B
|
Dec. 31, 2024 | USD 391.14 | -0.04% |
|
United States |
|
20 |
USD 3.65 B
|
Sept. 30, 2024 | USD 599.82 | 0.85% |
|
United States |
|
21 |
USD 3.24 B
|
Sept. 30, 2024 | USD 144.64 | 2.66% |
|
United States |
|
22 |
USD 2.96 B
|
Sept. 30, 2024 | USD 82.90 | 0.35% |
|
United States |
|
23 |
USD 2.81 B
|
Sept. 30, 2024 | USD 64.82 | 1.23% |
|
United States |
|
24 |
USD 2.76 B
|
Sept. 30, 2024 | USD 103.07 | 0.69% |
|
United States |
|
25 |
USD 2.64 B
|
Sept. 30, 2024 | USD 247.61 | 0.00% |
|
United States |
|
26 |
USD 2.62 B
|
Sept. 30, 2024 | USD 293.00 | -0.08% |
|
United States |
|
27 |
USD 2.57 B
|
Sept. 30, 2024 | USD 87.51 | -0.90% |
|
United States |
|
28 |
USD 2.46 B
|
Sept. 30, 2024 | USD 254.43 | 0.09% |
|
United States |
|
29 |
USD 2.25 B
|
Dec. 31, 2024 | USD 125.33 | 1.35% |
|
United States |
|
30 |
USD 2.18 B
|
Sept. 30, 2024 | USD 199.11 | -1.12% |
|
United States |
|
31 |
USD 2.06 B
|
Sept. 30, 2024 | USD 578.55 | 1.17% |
|
United States |
|
32 |
USD 2.00 B
|
Dec. 31, 2024 | USD 577.04 | 0.24% |
|
United States |
|
33 |
USD 1.99 B
|
Sept. 30, 2024 | USD 142.34 | -1.10% |
|
United States |
|
34 |
USD 1.93 B
|
Sept. 30, 2024 | USD 177.06 | 0.49% |
|
United States |
|
35 |
USD 1.87 B
|
Nov. 30, 2024 | USD 19.58 | -2.34% |
|
United States |
|
36 |
USD 1.64 B
|
Sept. 30, 2024 | USD 325.36 | 4.82% |
|
United States |
|
37 |
USD 1.60 B
|
Sept. 30, 2024 | USD 71.38 | -1.48% |
|
United States |
|
38 |
USD 1.56 B
|
Dec. 31, 2024 | USD 240.55 | 1.85% |
|
United States |
|
39 |
USD 1.54 B
|
Sept. 30, 2024 | USD 190.71 | 1.14% |
|
United States |
|
40 |
USD 1.50 B
|
Oct. 31, 2024 | USD 148.63 | -1.91% |
|
United States |
|
41 |
USD 1.50 B
|
Sept. 30, 2024 | USD 14.91 | -4.18% |
|
United States |
|
42 |
USD 1.49 B
|
Dec. 31, 2023 | USD 31.33 | -0.79% |
|
United States |
|
43 |
USD 1.38 B
|
Dec. 31, 2024 | USD 162.47 | -0.39% |
|
United States |
|
44 |
USD 1.38 B
|
Sept. 30, 2024 | USD 108.16 | -1.21% |
|
United States |
|
45 |
USD 1.28 B
|
Nov. 2, 2024 | USD 38.00 | 1.04% |
|
United States |
|
46 |
USD 1.28 B
|
Sept. 30, 2024 | USD 354.58 | 0.97% |
|
United States |
|
47 |
USD 1.25 B
|
Sept. 30, 2024 | USD 74.06 | -1.65% |
|
United States |
|
48 |
USD 1.15 B
|
Sept. 27, 2024 | USD 80.24 | -1.34% |
|
United States |
|
49 |
USD 1.12 B
|
Sept. 30, 2024 | USD 247.86 | -0.78% |
|
United States |
|
50 |
USD 1.11 B
|
Sept. 29, 2024 | USD 131.10 | -1.23% |
|
United States |
The Healthcare company in United States with the highest Operating Income is Elevance Health Inc. (NYSE: ELV) at USD 42.57 B.
The Healthcare company in United States with the lowest Operating Income is Walgreens Boots Alliance, Inc. (NasdaqGS: WBA) at USD -14.27 B.
The top 10 Healthcare companies in United States by Operating Income are Elevance Health Inc., UnitedHealth Group Incorporated, Walmart Inc., Johnson & Johnson, Merck & Co., Inc., Eli Lilly and Company, AbbVie Inc., HCA Healthcare, Inc., Bristol-Myers Squibb Company and Pfizer Inc..
The bottom 10 Healthcare companies in United States by Operating Income are Walgreens Boots Alliance, Inc., Moderna, Inc., Biohaven Pharmaceutical Holding Company Ltd., Insmed Incorporated, Revolution Medicines, Inc., Arrowhead Pharmaceuticals, Inc., Madrigal Pharmaceuticals, Inc., BridgeBio Pharma, Inc., Ultragenyx Pharmaceutical Inc. and Vaxcyte, Inc..